Interferon treatment for multiple myeloma.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007372:Interferons / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011070:Poly I-C / Q000627:therapeutic use; D011107:Polylysine / Q000627:therapeutic use / Q000031:analogs & derivatives
D011107:Polylysine; C019531:poly ICLC; D007372:Interferons; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C; D007213:Indomethacin